title: Brimonidine for erythema caused by rosacea.
abstract: Brimonidine gel (Mirvaso-Galderma) became available in February of this year for the symptomatic treatment of facial erythema associated with rosacea in adults.1 Here, we review the evidence on brimonidine gel and consider its place in the management of erythema associated with rosacea.
mesh_terms: D058647:Adrenergic alpha-2 Receptor Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D000068438:Brimonidine Tartrate; D000075202:Contraindications; D016527:Drug Costs; D004347:Drug Interactions; D004890:Erythema / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D011810:Quinoxalines / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D012393:Rosacea / Q000150:complications*
chemical_list: D058647:Adrenergic alpha-2 Receptor Agonists; D011810:Quinoxalines; D000068438:Brimonidine Tartrate